 Inclusion Criteria: - Fulfill the 1987 American Rheumatism Association ARA criteria for RA - Active RA at the time of enrollment, receipt of concomitant methotrexate at a dose of up to 25 mg a week is permitted - Screening lab results must demonstrate: 